R Sabia
Director Pharmaceutical Research and Development
Pharmaceutical
Medpace
Italy
Biography
Raffaele Sabia holds a degree in Medicine and a post-graduate diploma in Cardiovascular and has a long and rich experience in R&D roles in the pharmaceutical business. In 1990 he started his professional career at Schwarz Pharma as Medical Adviser for the Cardiovascular area and then became Clinical Research Manager. In 1997 he moved to AstraZeneca, where he covered different medical roles with growing responsibilities: first he was Senior Clinical Adviser Cardiovascular Area, then Medical Manager Cardiovascular & Metabolic Therapy Areas, later on Medical Affairs Director Primary Care, Neuroscience & Hospital; in 2006 he became, at Headquarters level, European Medical Affairs Director for the Cardiovascular Area. In the following year, as a part of the same Group, he came back to Italy as Vice President Medical, then Vice President Medical & Regulatory, and finally in 2012 Vice President Medical, Regulatory & Market Access, in charge of the management of Medical Affairs, Clinical Research, Drug Safety, Regulatory Affairs and Market Access Departments. Finally, in 2013 he joined Novartis Headquarters as Medical Head Region Europe – Cardio Metabolic Franchise, in charge for the entire region of design and implementation of the strategic clinical development and medical affairs programs related to Cardio Metabolic compounds. During his career he gained a significant experience in different therapeutic areas (Cardiovascular, Metabolic, Gastrointestinal, Respiratory, Neuroscience, Oncology, Anesthesiology, Anti-infective, Vaccines) and contributed to the success of several products. In July 2017 he joined Recordati S.p.A. as Director .Pharmaceutical Research and Development.
Research Interest
Clinical Research